Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2017-11-21 17:43:13 UTC |
---|
Update Date | 2022-03-07 03:18:14 UTC |
---|
HMDB ID | HMDB0240243 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Homochlorcyclizine |
---|
Description | Homochlorcyclizine, also known as curosajin or homoclomine, belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. In humans, homochlorcyclizine is involved in the homochlorcyclizine h1-antihistamine action pathway. Homochlorcyclizine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review very few articles have been published on Homochlorcyclizine. |
---|
Structure | CN1CCCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1 InChI=1S/C19H23ClN2/c1-21-12-5-13-22(15-14-21)19(16-6-3-2-4-7-16)17-8-10-18(20)11-9-17/h2-4,6-11,19H,5,12-15H2,1H3 |
---|
Synonyms | Value | Source |
---|
Curosajin | HMDB | (±)-homochlorcyclizine | HMDB | Homochlorocyclizine | HMDB | Homoclomine | HMDB | Homodamon | HMDB | Homorestar | HMDB | Lysilan | HMDB | N-(p-Chlorobenzhydryl)-n'-methylhomopiperazine | HMDB | NSC 25132 | HMDB | SA 97 | HMDB | Sankumin | HMDB | Wicron | HMDB | Homochlorcyclizine HCL | HMDB | Homochlorocyclizine hydrochloride | HMDB | Homochlorocyclizine monohydrochloride | HMDB | 1-((4-Chlorophenyl)phenylmethyl)hexahydro-4-methyl-1H-1,4-diazepine | HMDB | Homochlorcyclizine | HMDB, MeSH |
|
---|
Chemical Formula | C19H23ClN2 |
---|
Average Molecular Weight | 314.86 |
---|
Monoisotopic Molecular Weight | 314.1549764 |
---|
IUPAC Name | 1-[(4-chlorophenyl)(phenyl)methyl]-4-methyl-1,4-diazepane |
---|
Traditional Name | homochlorcyclizine |
---|
CAS Registry Number | 848-53-3 |
---|
SMILES | CN1CCCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1 |
---|
InChI Identifier | InChI=1S/C19H23ClN2/c1-21-12-5-13-22(15-14-21)19(16-6-3-2-4-7-16)17-8-10-18(20)11-9-17/h2-4,6-11,19H,5,12-15H2,1H3 |
---|
InChI Key | WEUCDJCFJHYFRL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Diphenylmethanes |
---|
Direct Parent | Diphenylmethanes |
---|
Alternative Parents | |
---|
Substituents | - Diphenylmethane
- 1,4-diazepane
- Chlorobenzene
- Diazepane
- Halobenzene
- Aralkylamine
- Aryl chloride
- Aryl halide
- Tertiary aliphatic amine
- Tertiary amine
- Organoheterocyclic compound
- Azacycle
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Homochlorcyclizine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homochlorcyclizine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 10V, Positive-QTOF | splash10-014i-0029000000-8a61986cf6d60bf81cda | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 20V, Positive-QTOF | splash10-0gb9-3096000000-959bed2bb20cae706198 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 40V, Positive-QTOF | splash10-0udl-9240000000-e1c510f4600b8a191aa9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 10V, Negative-QTOF | splash10-03di-0009000000-dc2748d860fa60954b1d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 20V, Negative-QTOF | splash10-03di-0159000000-65f5c34b0b35e0ac26b6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 40V, Negative-QTOF | splash10-02fx-5490000000-940d537678147878c1c3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 10V, Positive-QTOF | splash10-014i-0039000000-e5538a12567efbc3dfa8 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 20V, Positive-QTOF | splash10-0uxr-0094000000-a3c4471119f072f6e962 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 40V, Positive-QTOF | splash10-0udi-1290000000-05fb262b2cc10b1e2916 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 10V, Negative-QTOF | splash10-03di-0009000000-c54768588510ddbc9bef | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 20V, Negative-QTOF | splash10-0ik9-0089000000-970bf509629d7033eebd | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homochlorcyclizine 40V, Negative-QTOF | splash10-0ik9-1491000000-b2affbdb4464c5870a0d | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Suzuki A, Yasui-Furukori N, Mihara K, Kondo T, Furukori H, Inoue Y, Kaneko S, Otani K: Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. Ther Drug Monit. 2003 Apr;25(2):192-6. [PubMed:12657913 ]
|
---|